Randall B. Brenner, Chief Development & Regulatory at Paratek Pharmaceuticals, Inc. (PRTK), sold 7,674 shares at $3.98 ($31K) on 2019-10-03, disclosed to the SEC on 2019-10-07.
Open-market sale of $31k PRTK by Chief Development & Regulatory. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PRTK | SELL | 2022-12-14 | $58K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $12K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $104K | — | Filing → |